Gemcitabine controlled release - Trigone Pharma
Alternative Names: Gemcitabine prolonged release - Trigone Pharma; TRG-140Latest Information Update: 16 Jun 2023
At a glance
- Originator Trigone Pharma
- Class Amines; Antineoplastics; Deoxyribonucleosides; Fluorinated hydrocarbons; Ketones; Pyrimidine nucleosides; Pyrimidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bladder cancer
Most Recent Events
- 16 Jun 2023 Chemical structure information added
- 27 Dec 2022 Preclinical trials in Bladder cancer in Israel (Controlled release) (Trigone Pharma pipeline, December 2022)